Tristel Regulatory News (TSTL)

23 Dec 2005 12:22

Tristel PLC23 December 2005 Tristel PLC ("Tristel" or the "Company") 23 December 2005 Grant of Options Tristel, the AIM listed provider of infection control products, announces thatit has granted options to employees over 660,000 ordinary shares of 1p each ("Shares"), under the Company's EMI Option Scheme. The options have an exerciseprice of 53.75p and vest 25% from today and then in 3 equal tranches on 23December over the following three years. The options, once vested, can beexercised by 23 December 2015. In addition Paul Swinney, Chief Executive Officer, has been granted options over250,000 Shares under the Unapproved Option Scheme. The options have an exerciseprice of 59.5p, vesting 25% from today and then in 3 equal tranches on 23December over the following three years. The options, once vested, must beexercised by 23 December 2015. Paul Swinney does not have any other options andis currently interested in 2,713,986 Shares, being 11.39% of the Company'sissued share capital. For further details please contact: Teather & Greenwood LimitedRobert Naylor / Harry NicholasTel: 020 7426 9000 This information is provided by RNS The company news service from the London Stock Exchange